Axel Walther
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.
Journal: EClinicalMedicine
Published: April 09, 2026
The Influence of Recall and Timing of Assessment on the Estimation of Quality-Adjusted Life-Years When Health Fluctuates Recurrently.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 25, 2024
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: June 11, 2024
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
Journal: British journal of cancer
Published: October 31, 2022
British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: November 05, 2021
Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses.
Journal: The patient
Published: September 26, 2021
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: July 20, 2020
Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment.
Journal: Cancer treatment reviews
Published: June 29, 2020
Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
Journal: British journal of cancer
Published: March 14, 2019
Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Journal: PLoS medicine
Published: November 27, 2018
Copy number signatures and mutational processes in ovarian carcinoma.
Journal: Nature genetics
Published: September 04, 2017
Last Updated: 09/26/2026